APA (7th ed.) Citation

Rivolo, S., Fusco, M. D., Polanco, C., Kang, A., Dhanda, D., Savone, M., . . . Soto, J. (2021). Cost-effectiveness analysis of apixaban versus vitamin K antagonists for antithrombotic therapy in patients with atrial fibrillation after acute coronary syndrome or percutaneous coronary intervention in Spain. Public Library of Science (PLoS).

Chicago Style (17th ed.) Citation

Rivolo, Simone, Manuela Di Fusco, Carlos Polanco, Amiee Kang, Devender Dhanda, Mirko Savone, Aristeidis Skandamis, Thitima Kongnakorn, and Javier Soto. Cost-effectiveness Analysis of Apixaban Versus Vitamin K Antagonists for Antithrombotic Therapy in Patients with Atrial Fibrillation After Acute Coronary Syndrome or Percutaneous Coronary Intervention in Spain. Public Library of Science (PLoS), 2021.

MLA (8th ed.) Citation

Rivolo, Simone, et al. Cost-effectiveness Analysis of Apixaban Versus Vitamin K Antagonists for Antithrombotic Therapy in Patients with Atrial Fibrillation After Acute Coronary Syndrome or Percutaneous Coronary Intervention in Spain. Public Library of Science (PLoS), 2021.